Given the upregulation of PLK1 in breast cancer, PLK1 knockdown was achieved in two TNBC cell lines (MDA-MB-231 and HCC1937) by introducing small interfering RNA against PLK1 (si-PLK1-1/2/3) and validated using immunoblotting. The gene discussed is PLK1; the disease is breast carcinoma.